Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $81.07 and last traded at $81.07, with a volume of 6150 shares. The stock had previously closed at $81.07.
Pharma Mar Stock Performance
The business’s fifty day moving average is $73.13 and its 200 day moving average is $50.17. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Read More
- Five stocks we like better than Pharma Mar
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How to Start Investing in Real Estate
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- The 3 Best Fintech Stocks to Buy Now
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
